CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.50
-0.20 (-1.90%)
Aug 22, 2025, 4:35 PM GMT+1
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 4.20 million as of August 22, 2025. Its market cap has increased by 210.97% in one year.
Market Cap
4.20M
Enterprise Value
2.91M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.50
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 4.20M, a decrease of -85.14%. That is a compound annual growth rate of -9.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 4.20M | 16.73% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | 22.08M | 31.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.71B |
| GSK plc | 59.74B |
| Haleon | 33.11B |
| Smith & Nephew | 12.13B |
| ConvaTec Group | 4.99B |
| Hikma Pharmaceuticals | 4.01B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 2.03B |